Development, Pharmacokinetics and Antimalarial Evaluation of Dose Flexible 3D Printlets of Dapsone for Pediatric Patients
AAPS PharmSciTech · 2024
DOI: 10.1208/s12249-024-02935-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift AAPS PharmSciTech, 2024. Verfasst von Adnan A Khan und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Engineering Medicine, Texas A&M University, Houston, Texas, 77030, USA. Hauptthemen laut MEDLINE: Antimalarials, Rats, Sprague-Dawley, Dapsone, Printing, Three-Dimensional. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
The focus of current studies was to fabricate dose flexible printlets of dapsone (DDS) for pediatric patients by selective laser sintering (SLS) 3D printing method, and evaluate its physicochemical, patient in-use stability, and pharmacokinetic attributes. Eight formulations were fabricated using Kollicoat® IR, Eudragit® L-100-55 and StarCap®as excipients and evaluated for hardness, disintegration, dissolution, amorphous phase by differential scanning calorimetry and X-ray powder diffraction, in-use stability at 30 oC/75% RH for a month, and pharmacokinetic study in Sprague Dawley rats. The hardness, and disintegration of the printlets varied from 2.6±1.0 (F4) to 7.7±0.9 (F3) N and 2.0±0.4 (F2) to 7.6±0.6 (F3) sec, respectively. The drug was partially present as an amorphous form in the printlets. The drug was completely (>85%) dissolved in 20 min. No change in drug form or dissolution extent was observed after storage at in use condition. Pharmacokinetic profiles of both formulations (tablets and printlets) were almost superimposable with no statistical difference in pharmacokinetic parameters (Tmax, Cmax, and AUC0-¥)between formulations (p>0.05). Values of EC50 (half maximal effective concentration) and EC90 (maximal concentration inducing 90% maximal response) were 0.50±0.15 and 1.32±0.26 mM, 0.41±0.06 and 1.11±0.21, and 0.42±0.13 and 1.36±0.19 mM for DDS, printlet and tablet formulations, respectively, and differences were statistically insignificant (p>0.05). In conclusion, tablet and printlet formulations are expected to be clinical similar, thus clinically interchangeable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Engineering Medicine, Texas A&M University, Houston, Texas, 77030, USA.
- Texas A&M Health Science Center, Irma Lerma Rangel School of Pharmacy, Texas A&M University, Reynolds Medical Sciences Building, Suite 308, College Station, Texas, 77843, USA.
- Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, 75390, USA.
- Department of Biology, Texas A&M University, College Station, Texas, 77843, USA.
- Department of Engineering Technology & Industrial Distribution, College of Engineering, Texas A&M University, College Station, Texas, 77843, USA.
- Department of Cell Biology and Genetics, School of Medicine, Texas A&M Health Science Center, Texas A&M University, College Station, Texas, 77843, USA.
Förderung
- NICHD NIH HHS
Zitieren
APA
Khan, A. A., Khuroo, T., Mohamed, E. M., Dharani, S., Canberk, K., Zhang, X., Sangaré, L. O., Kuttolamadom, M. A., Rice-Ficht, A. C., & Rahman, Z. (2024). Development, Pharmacokinetics and Antimalarial Evaluation of Dose Flexible 3D Printlets of Dapsone for Pediatric Patients. AAPS PharmSciTech. https://doi.org/10.1208/s12249-024-02935-2
Vancouver
Khan AA, Khuroo T, Mohamed EM, Dharani S, Canberk K, Zhang X, et al. Development, Pharmacokinetics and Antimalarial Evaluation of Dose Flexible 3D Printlets of Dapsone for Pediatric Patients. AAPS PharmSciTech. 2024. doi:10.1208/s12249-024-02935-2
BibTeX
@article{Khan2024,
author = {Khan, Adnan A and Khuroo, Tahir and Mohamed, Eman M and Dharani, Sathish and Canberk, Kayalar and Zhang, Xiaoyu and Sangaré, Lamba Omar and Kuttolamadom, Mathew A and Rice-Ficht, Allison C and Rahman, Ziyaur},
title = {Development, Pharmacokinetics and Antimalarial Evaluation of Dose Flexible 3D Printlets of Dapsone for Pediatric Patients},
journal = {AAPS PharmSciTech},
year = {2024},
doi = {10.1208/s12249-024-02935-2}
}
EUVIMED